HOME >> BIOLOGY >> NEWS
Report in Science on x-ray crystal structure of matrix Metalloproteinase-2 (MMP-2)

MMP-2 is a key target for anti-cancer drug development

Research Triangle Park, N.C.--June 4, 1999-- BioStratum Incorporated announced today the publication of a paper in the journal SCIENCE (volume 284, pages 1667-1670) reporting the three-dimensional structure of the matrix metalloproteinase-2 (MMP-2), a key molecular target for a number of anti-cancer drug candidates currently in clinical development. This work was completed by one of BioStratum's founding scientists, Dr. Karl Tryggvason of the Karolinska Institute, Stockholm, Sweden.

The elucidated structure of MMP-2 provides valuable information on the function and regulation of this important enzyme, and provides for the design of improved MMP-2 specific inhibitors for clinical evaluation. BioStratum owns intellectual property rights to this technology and to new and improved MMP-2 inhibitors that may be identified.

Matrix metalloproteinases (MMPs) are involved in tissue growth and wound repair. MMPs work by degrading substances in the extracellular matrix (the area outside of cells) thereby enabling the movement and expansion of cells, the deposition of new extracellular matrix, and the subsequent development of new tissue. MMP-2 acts directly on type IV collagen, a principal component of the basal lamina, a specialized form of the extracellular matrix. The activation of MMPs has been implicated in the invasive growth and spread of tumors. Several clinical studies are in progress evaluating the effectiveness of MMP inhibitors as anti-cancer agents, and many more are projected to enter clinical trials in the near future.

The elucidated molecular structure is the culmination of seven years of effort in Dr. Tryggvason?s laboratory. "This advance is providing important insights into the catalytic and regulatory mechanisms of this enzyme. It also provides an additional tool to aid in the design of improved MMP inhibitors to combat the spread of cancer," said Dr. Tryggvason.<
'"/>

Contact: J. Wesley Fox, Ph.D.
info@biostratum.com
919-572-6515
Noonan/Russo Communications
4-Jun-1999


Page: 1 2 3

Related biology news :

1. Report outlines vision and recommendations for microbiology in the 21st Century
2. Report outlines steps needed to lessen smallpox threat
3. Reporters from Science Magazine to receive ASM Public Communications Award
4. Report in BioScience details global decline of nonmarine mollusks
5. National Academies news: Report on EPAs particulate matter research
6. Report details growing climate change threat to coral reefs
7. Report to aid nation in managing freshwaters
8. Report examines use of antibiotics in agriculture
9. Report offers action plan for curbing diseases that kill millions
10. Report focuses on the science and safety of genetically modified crops
11. Report considers role of science in a world made vulnerable by terrorism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... ... advanced software solutions for biopharmaceutical R&D, today announced Genedata Imagence®, the industry’s ... (HCS) images. The deep learning-based solution accelerates, by orders of magnitude, the ...
(Date:10/16/2018)... ... ... Our own cells may be the answer to eliminating chronic neck or ... and pain management specialist Jason Arora, DO, who says using a patient’s blood plasma, ... patient’s bone marrow are proving effective therapies for eliminating discogenic pain, namely pain caused ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... development, announces a new publication titled, “ Graphene-based Biosensor for On-Chip Detection of ... describes Agile R100 as a “new portable digital device for biosensing… that can ...
Breaking Biology News(10 mins):
(Date:10/16/2018)... ... October 16, 2018 , ... ... Moreno-Indias, PhD, Senior Researcher at the Biomedical Research Institute of Malaga, University ... Network of Obesity and Nutrition, to its Scientific Advisory Board. Joining the board ...
(Date:10/16/2018)... ... October 15, 2018 , ... ... the visualization of histopathology slides by eye wherein key features are used for ... diagnosis and research, it is highly limited in that it is a qualitative ...
(Date:10/13/2018)... ... October 12, 2018 , ... The Laser ... and commercialization, celebrates its 50th birthday in New York’s Times Square today, ahead ... (ICALEO) conference. , In celebration of its 50 years, LIA showed thanks ...
(Date:10/11/2018)... NEW YORK, NY (PRWEB) , ... October 11, ... ... critical role in the treatment of diseases like leukemia, lymphoma, sickle cell anemia, ... these promising new therapies. Quick Specialized Healthcare Logistics’ new e-book provides expert advice ...
Breaking Biology Technology:
Cached News: